ulbp 2 5 6 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
ulbp 2 5 6
Ulbp 2 5 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 139 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulbps+2+5+6/Human+ULBP-2%2F5%2F6+APC-conjugated+Antibody/pm41826286-310-41-54
Average 95 stars, based on 139 article reviews
Ulbp 2 5 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 139 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulbps+2+5+6/Human+ULBP-2%2F5%2F6+APC-conjugated+Antibody/pm41826286-310-41-54
Average 95 stars, based on 139 article reviews
ulbp 2 5 6 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Bioprocessing:Article Title: Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis. Article Snippet: .. Conjugated CD3 (#552127), PD-1 (#565935) (BD Pharmingen, USA), and CD314 (anti-NKG2D) (#130–111-846), CD8 (#130–110-679), CD56 (#130–113-310) (Miltenyi Biotec, Germany) monoclonal antibodies (mAbs) were used to characterize phenotype of MSLN-CAR.CIK, and a conjugated anti-F(ab′)2 fragment Ab (#115–606-072, Jackson ImmunoResearch Europe Ltd) to detect CAR expression. mOC cells were stained with conjugated mAbs for the expression of MIC A/B (#558352, BD Pharmingen, USA) and Article Title: Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis Article Snippet: .. Conjugated CD3 (#552127), PD-1 (#565935) (BD Pharmingen, USA), and CD314 (anti-NKG2D) (#130–111-846), CD8 (#130–110-679), CD56 (#130–113-310) (Miltenyi Biotec, Germany) monoclonal antibodies (mAbs) were used to characterize phenotype of MSLN-CAR.CIK, and a conjugated anti-F(ab′)2 fragment Ab (#115–606-072, Jackson ImmunoResearch Europe Ltd) to detect CAR expression. mOC cells were stained with conjugated mAbs for the expression of MIC A/B (#558352, BD Pharmingen, USA) and Expressing:Article Title: Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis. Article Snippet: .. Conjugated CD3 (#552127), PD-1 (#565935) (BD Pharmingen, USA), and CD314 (anti-NKG2D) (#130–111-846), CD8 (#130–110-679), CD56 (#130–113-310) (Miltenyi Biotec, Germany) monoclonal antibodies (mAbs) were used to characterize phenotype of MSLN-CAR.CIK, and a conjugated anti-F(ab′)2 fragment Ab (#115–606-072, Jackson ImmunoResearch Europe Ltd) to detect CAR expression. mOC cells were stained with conjugated mAbs for the expression of MIC A/B (#558352, BD Pharmingen, USA) and Article Title: Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis Article Snippet: .. Conjugated CD3 (#552127), PD-1 (#565935) (BD Pharmingen, USA), and CD314 (anti-NKG2D) (#130–111-846), CD8 (#130–110-679), CD56 (#130–113-310) (Miltenyi Biotec, Germany) monoclonal antibodies (mAbs) were used to characterize phenotype of MSLN-CAR.CIK, and a conjugated anti-F(ab′)2 fragment Ab (#115–606-072, Jackson ImmunoResearch Europe Ltd) to detect CAR expression. mOC cells were stained with conjugated mAbs for the expression of MIC A/B (#558352, BD Pharmingen, USA) and Staining:Article Title: Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis. Article Snippet: .. Conjugated CD3 (#552127), PD-1 (#565935) (BD Pharmingen, USA), and CD314 (anti-NKG2D) (#130–111-846), CD8 (#130–110-679), CD56 (#130–113-310) (Miltenyi Biotec, Germany) monoclonal antibodies (mAbs) were used to characterize phenotype of MSLN-CAR.CIK, and a conjugated anti-F(ab′)2 fragment Ab (#115–606-072, Jackson ImmunoResearch Europe Ltd) to detect CAR expression. mOC cells were stained with conjugated mAbs for the expression of MIC A/B (#558352, BD Pharmingen, USA) and Article Title: Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis Article Snippet: .. Conjugated CD3 (#552127), PD-1 (#565935) (BD Pharmingen, USA), and CD314 (anti-NKG2D) (#130–111-846), CD8 (#130–110-679), CD56 (#130–113-310) (Miltenyi Biotec, Germany) monoclonal antibodies (mAbs) were used to characterize phenotype of MSLN-CAR.CIK, and a conjugated anti-F(ab′)2 fragment Ab (#115–606-072, Jackson ImmunoResearch Europe Ltd) to detect CAR expression. mOC cells were stained with conjugated mAbs for the expression of MIC A/B (#558352, BD Pharmingen, USA) and Incubation:Article Title: Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis. Article Snippet: .. Conjugated CD3 (#552127), PD-1 (#565935) (BD Pharmingen, USA), and CD314 (anti-NKG2D) (#130–111-846), CD8 (#130–110-679), CD56 (#130–113-310) (Miltenyi Biotec, Germany) monoclonal antibodies (mAbs) were used to characterize phenotype of MSLN-CAR.CIK, and a conjugated anti-F(ab′)2 fragment Ab (#115–606-072, Jackson ImmunoResearch Europe Ltd) to detect CAR expression. mOC cells were stained with conjugated mAbs for the expression of MIC A/B (#558352, BD Pharmingen, USA) and Article Title: Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis Article Snippet: .. Conjugated CD3 (#552127), PD-1 (#565935) (BD Pharmingen, USA), and CD314 (anti-NKG2D) (#130–111-846), CD8 (#130–110-679), CD56 (#130–113-310) (Miltenyi Biotec, Germany) monoclonal antibodies (mAbs) were used to characterize phenotype of MSLN-CAR.CIK, and a conjugated anti-F(ab′)2 fragment Ab (#115–606-072, Jackson ImmunoResearch Europe Ltd) to detect CAR expression. mOC cells were stained with conjugated mAbs for the expression of MIC A/B (#558352, BD Pharmingen, USA) and |